Duration of Second or Greater Complete Clinical Remission In Ovarian Cancer: Exploring Potential Endpoints for Clinical Trials

PURPOSE: To explore benchmarks for future consolidation strategies, we evaluated a strictly defined (normal CA-125 and normal CT) second-complete-remission (CR) ovarian cancer population for 1) the median progression-free survival (PFS), 2) the frequency with which second remission exceeds first, an...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Harrison, Michelle L, Gore, Martin E, Spriggs, David, Kaye, Stan, Iasonos, Alexia, Hensley, Martee, Aghajanian, Carol, Venkatraman, Ennapadam, Sabbatini, Paul
Формат: Artigo
Язык:Inglês
Опубликовано: 2007
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2694792/
https://ncbi.nlm.nih.gov/pubmed/17614127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2007.05.008
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы